Work

Impact of proton pump inhibitor (PPI) pharmacogenomics (PGx) on toxicities associated with immune checkpoint inhibitor (ICI) therapy.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.12128

Authors: Laura Carpin Kennedy, Rajat Mohindra, Jessica Mezzanotte Sharpe, Sarah Louise Mycroft, Justin M. Balko, G. Scott Chandler, Svetlana Lyalina

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, Roche (Switzerland), Roche (United Kingdom), Vanderbilt University Medical Center, Genentech

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410808454

Cites:

Cited by:

Related to: 10